Back

Duration of dual anti platelet therapy in elective drug coated balloon angioplasty

27 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Interventional cardiology - General aspects Devices ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Natasha Corballis

Norfolk and Norwich University Hospital, Norwich (United Kingdom of Great Britain & Northern Ireland)

11 More presentations in this session

Presentation thumbnail
Doctor S. Burgess (Sydney, AU)
Abstract Slides
Presentation thumbnail
Professor K. Kozuma (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Miss F. Saraiva (Porto, PT)
Abstract
Presentation thumbnail
Doctor S. Mehta (Miami, US)
Abstract Slides
Presentation thumbnail
Doctor M. Andreassi (Pisa, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Interventional cardiology - General aspects

The Event

Event poster

ESC Congress 2018

27 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Lesion preparation as an independent determinant of outcomes after drug-coated balloon angioplasty: evidence from clinical, angiographic and functional assessment in observational cohort
19 February 2026
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Presentation
Thirty-days versus standard duration of dual antiplatelet treatment after percutaneous coronary interventions: a systematic review and meta-analysis
27 August 2022
thumbnail
Congress Presentation
Impact of stepwise dual antiplatelet therapy de-escalation in patients with high bleeding risk undergoing drug-coated balloon angioplasty: Insights from the REC-CAGEFREE II trial
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources